about
SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria20 µg versus >20 µg estrogen combined oral contraceptives for contraceptionImmediate start of hormonal contraceptives for contraceptionExpectant care versus surgical treatment for miscarriage20 µg versus >20 µg estrogen combined oral contraceptives for contraceptionSteroid hormones for contraception in menFertility awareness-based methods for contraceptionSpermicide used alone for contraceptionSteroid hormones for contraception in menDiaphragm versus diaphragm with spermicides for contraceptionTenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trialTerbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth.SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.Do clinical experts rely on the Cochrane library?Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.Hormone replacement therapy and the risk of death from breast cancer: a systematic review.Magnesium sulfate tocolysis: time to quit.The diaphragm with and without spermicide for contraception: a Cochrane review.Validation of a Trauma Questionnaire in veteran women.Diagnostic efficiency of home pregnancy test kits. A meta-analysis.Is this woman perimenopausal?Steroid hormones for contraception in men: systematic review of randomized controlled trials.Twenty micrograms vs. >20 microg estrogen oral contraceptives for contraception: systematic review of randomized controlled trials.Fertility awareness-based methods for contraception: systematic review of randomized controlled trials.Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review.Progestogen-only contraceptive use among breastfeeding women: a systematic review.Safety of quinacrine contraceptive pellets: results from 10-year follow-up in Vietnam.Quinacrine sterilization and gynecologic cancers: a case-control study in northern Vietnam.ACP Journal Club. Human papillomavirus 16/18 AS04-adjuvanted vaccine prevented cervical intraepithelial neoplasia in young women.Validation of a job aid to rule out pregnancy among family planning clients in Nicaragua.Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy.The Good Clinical Practice guideline: a bronze standard for clinical research.Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial.Young women's risk of first HPV infection was high and increased when the first male partner was sexually experiencedContraceptive effectiveness of two insertions of quinacrine: results from 10-year follow-up in VietnamRandomized crossover trial comparing the eZ·on™ plastic condom and a latex condomSetting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening*1A view of reviewsEffect of estrogen replacement therapy on corrected thrombolysis in myocardial infarction frame countYoung women's risk for first HPV infection was high and increased when the first male partner was sexually experienced
P50
Q21144355-594EE012-C95D-442F-A9D9-7D9A5DA588BCQ24240908-7E832D82-E644-45B7-B0E8-A8A54A892001Q24242950-CF7850C9-95A0-4B12-912E-2BB3976FCA8EQ24243908-EA28D3B0-C581-4AB1-89D9-F588A4C93DF5Q24243992-6D49BC43-F4E5-41A9-8EBB-D5D4D53F45F9Q24245039-4896A098-4E14-4E9F-BCDB-88D51D48DA63Q24245867-511E5336-FED5-49A3-B101-B781623A5063Q24245916-A3D0D06D-A269-49FB-804C-4C7A77EDE32BQ24246673-5A38917C-8BA9-4B49-B84D-5D289EF79783Q24250232-CB4925E3-6B32-45DE-AFE2-8214E0DF3649Q28469218-5598DE55-574E-4BDD-A7B6-E1393D6FB85FQ30880356-42526F4E-4125-4A67-BC63-1F2DD9E9436FQ33311277-B9721C9C-345F-4C00-9493-466678AA478FQ33317736-8B26BEA1-0021-4EF3-910D-A86A223EE116Q33923869-EC0E6703-651E-40FF-95C6-5260AE8869DEQ34538056-3463EB8D-0D17-4C7D-BA9C-C3E9BB30CEE0Q34570369-C08B9C39-4049-4A44-8B43-93DEBAF3BF1EQ34582731-4A93DB45-1D5F-4E9E-9F7C-0742559221A1Q34749731-3FC26F2A-0673-40D0-A62F-63D7D44DB4F1Q34753607-542E57C0-0F35-418E-9BED-23C758C4B3BAQ35067025-DA67DD94-C88F-4369-8DBE-9DB04B7A1D99Q36039254-31AC605C-C83B-4933-823B-103C067AFBD2Q36049436-B6892F02-A2D5-4B0A-85C1-8B824DAACD93Q36196796-2D91B7C5-FD6D-456E-90BD-30B5A51B16F8Q37676787-45ED53FF-7044-4B79-BC52-AD977851C210Q37777442-451BC1F2-B459-4005-9F0E-FAB9272D6383Q44595137-7FB5E909-0D89-4AC8-AEEA-E27895C6451EQ45119654-47F07414-9C73-4962-AD5E-608F6F580EF9Q53486883-D1CDD6E7-8273-4A6D-A0A6-01AA4C758DB5Q53544621-923C3A70-EB9C-4543-852C-31EFA54C0EE2Q53562034-0B511962-32C5-4021-A471-710148C9C582Q53618862-6DDA9D66-1553-415A-AD89-A35FDFC54FA5Q53657743-25C57A7E-4871-4ECB-BB8D-D381248DD73CQ58206698-9D093564-B535-4BFC-9471-20DC88CBF9F1Q58206702-B74F06D3-B154-42BC-BE47-7095CEF29FA6Q58206736-6BFACEC3-69D2-48C6-997A-EA2276EFD90DQ58206741-DD960FD2-ABFD-41DD-8B30-0CFF4946A924Q58206747-0DF06B86-F24A-4091-8DE4-5D6ED810E403Q58206750-EB827D2D-2E80-4FCE-A203-E6C2AB492DFEQ58876510-2447B5FC-661D-47B7-B588-793D92E7DD38
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kavita Nanda
@ast
Kavita Nanda
@en
Kavita Nanda
@es
Kavita Nanda
@nl
Kavita Nanda
@sl
type
label
Kavita Nanda
@ast
Kavita Nanda
@en
Kavita Nanda
@es
Kavita Nanda
@nl
Kavita Nanda
@sl
prefLabel
Kavita Nanda
@ast
Kavita Nanda
@en
Kavita Nanda
@es
Kavita Nanda
@nl
Kavita Nanda
@sl
P106
P21
P31
P496
0000-0001-7650-2929